WPI 3171 (Alendronate 35 mg)
Pill imprint WPI 3171 has been identified as Alendronate sodium 35 mg.
Alendronate is used in the treatment of prevention of osteoporosis; osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not subject to the Controlled Substances Act.
See also related documents.
- 35 mg
- Prescription only
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|21695-0901||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about alendronate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.